Clinical
Association Of Clinical Research Professionals
Related Pages
Association Of Clinical Research Professionals
Clinical Anatomy
Clinical Audit
Clinical Cardiology
Clinical Case Management
Clinical Cases
Clinical Contract
Clinical Data Warehousing
Clinical Diagnosis
Clinical Educator
Clinical Engineering
Clinical Exercise Physiologist
Clinical Global Impression Scale
Clinical Hours
Clinical Imaging
Clinical Kinesiology
Clinical Lab Scientist
Clinical Laboratory
Clinical Microbiology Newsletter
Clinical News
Clinical Nurse Specialist Job Description
Clinical Nursing Skills
Clinical Pastoral Education
Clinical Pathology
Clinical Pathways
Clinical Pharmacology
Clinical Project Manager
Clinical Psychologists
Clinical Reasoning
Clinical Research Center
Clinical Research Management
Clinical Research Study
Clinical Services
Clinical Supervisor
Clinical Therapeutics
Clinical Toxicology
Clinical Trial Design
Clinical Trial Registry
Diabetes Clinical Trial
Good Clinical Practices
In Clinical Data Management
Journal Of Clinical Epidemiology
Journal Of Clinical Psychology
Licensed Clinical Psychologist
Liver Cancer Clinical Trials
Ortho Clinical Diagnostics
Registered Clinical Counsellor
Drug-trial center falls to trends - Indianapolis Star
bi13511348
The Money Times
Drug-trial center falls to trends
Indianapolis Star, United States -
16 hours ago
By Erika D. Smith When the Lilly Center for Medical Science ends trials Indianapolis later year, be the end of an era at Eli Lilly
Covance buys Eli Lilly facility 10-year deal
Forbes
UPDATE 1-Lilly farms out some lab services to Covance
Reuters
Drug giant Lilly transferring trial monitoring to
Local Tech Wire
newratings.com - Pharma Times (subscription)
all 93 news articles
..
We need cancer drugs. NICE must go - Times Online
bi13511348
ITV.com
We need cancer drugs. NICE must go
Times Online, UK -
1 hour ago
NICE was set up 1999 a brief to provide guidelines and technology assessments for England and Wales (there a separate panel for
Surgery 'saves more lives from cancer than drugs'
Telegraph.co.uk
Nice has got prescription wrong
guardian.co.uk
UK Says Kidney Cancer Drugs Aren?t Worth the Cost
Wall Street Journal Blogs
The Press Association - BBC News
all 261 news articles
..
Supervisor Chaplain Clinical Pastoral Education - Spiritual Care - Seattle Times
bi13511348
Supervisor Chaplain Pastoral Education - Spiritual Care
Seattle Times, United States -
11 minutes ago
This a regular, salaried, Day shift position, 0.6 FTE, 24 hours per week. This position eligible for benefits. Provide spiritual and emotional care to
..
Affymax Announces Favorable Data Monitoring Committee Review of - MarketW
bi13511348
Affymax Announces Favorable Data Monitoring Committee Review of
MarketWatch -
2 hours ago
Affymax conducting Phase 3 trials for Hematide to treat anemia associated chronic renal failure and Takeda initiated a Phase 1
..
US Renal Care Appoints Chief Medical Officer - MarketWatch
bi13511348
US Renal Care Appoints Chief Medical Officer
MarketWatch -
6 hours ago
During time he oversaw all program development and helped grow the Company from 37 facilities the US to more than 500 internationally.
..
New Prostate Cancer Test Ready for Commercialization Following - Marke
bi13511348
OverTheLimit.info
New Prostate Cancer Test Ready for Commercialization Following
MarketWatch -
8 hours ago
today announced that HDC's new gene-based molecular diagnostic test for prostate cancer has now successfully completed it's Phase III double-blind
Prostate cancer rate spurs campaigners
So Md News
Task Force Says Men Age 75 and Older Should Not Be Screened For
Earthtimes (press release)
USPSTF Recommends Against Prostate Cancer Screening Men 75
Medscape (subscription)
Forbes - MedPage Today
all 787 news articles
..
Enrollment of Breast and Ovarian Cancer Patients Commenced for - MarketWatch
bi13511348
Enrollment of Breast and Ovarian Cancer Patients Commenced for
MarketWatch -
8 hours ago
Currently the AE37 vaccine the subject of a Phase II trial patients breast cancer and a Phase I trial prostate cancer patients.
Enrollment of Breast and Ovarian Cancer Patients Commenced for
RedOrbit
all 7 news articles
..
CLX Medical, Inc. Announces Results of Meetings at AACC Annual - MarketWatch
bi13511348
CLX Medical, Inc. Announces Results of Meetings at AACC Annual
MarketWatch -
8 hours ago
AACC's Lab Expo, the largest gathering of laboratory industry companies the world, was anticipated to include 1800 booths and 650 exhibitors.
..
Praxis Launches Patient Recruitment Campaign For 2nd Protocol of - Market
bi13511348
Praxis Launches Patient Recruitment Campaign For 2nd Protocol of
MarketWatch -
6 hours ago
According to David Fox, President and CEO of Praxis, "This a significant study the women's health area, and our expertise and strategic
..
Cyclacel to Present At the Canaccord Adams Global Growth Conference - MarketW
bi13511348
Earthtimes (press release)
Cyclacel to Present At the Canaccord Adams Global Growth Conference
MarketWatch -
4 hours ago
Three orally-available Cyclacel drugs are development. Sapacitabine (CYC682), a cell cycle modulating nucleoside analog, Phase 2 studies
La Jolla Pharmaceutical Company to Present at Canaccord Adams
WELT ONLINE
Delcath Systems to Present at the 28th Annual Canaccord Adams
MarketWatch
Cell Genesys to Present at the 28th Annual Canaccord Adams Global
MarketWatch
MarketWatch - MarketWatch
all 370 news articles
..
(OTC: CLXN) CLX Medical Reaches Agreement With European - Stockhouse
bi13511348
(OTC: CLXN) CLX Medical Reaches Agreement With European
Stockhouse, Canada -
2 hours ago
CLX Medical, Inc. (OTCBB: CLXN) announced today Positive Results of meetings at American Association for Chemistry (AACC) Annual Meeting and
..
For Lab Automation Systems, Being Open Is Better - MarketWatch
bi13511348
For Lab Automation Systems, Being Open Is Better
MarketWatch -
4 hours ago
New technologies based on manufacturing automation have been transforming hospital laboratories and corporate drug development laboratories ever
..
Metabasis Therapeutics Announces Second Quarter 2008 Results and - Centre
bi13511348
Metabasis Therapeutics Announces Second Quarter 2008 Results and
Centre Daily Times, PA -
1 hour ago
The decreases for the quarter and six-month period were mainly due to decreased development costs for MB07803, MB07133 and MB07811 and stock-based
Inhibitex Reports Initiation of Multiple Ascending Dose Trial of
PharmaLive.com (press release)
all 3 news articles
..
Honda Cbr Accessories - Home